Storys aus Portugal

Filtern
  • 02.06.2025 – 11:39

    BIAL SA

    BIAL Announces Oral Presentation at GBA1 Meeting 2025

    Porto, Portugal (ots/PRNewswire) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being held June 5-7, 2025, in Montreal, Canada. The GBA1 Meeting 2025 is hosted by McGill University, focusing on all aspects of GBA1 research, from basic ...

  • 21.04.2023 – 17:40

    Aurisco

    Aurisco Expands Oligonucleotide Capacity and Launches New Website

    SETÚBAL, Portugal (ots/PRNewswire) - The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs. The new website shows how R&D and Innovation is the driving force of its sustainable growth, featuring its technologies, capabilities, services and products, including Oligonucleotides, peptides and small molecules ...

  • 20.04.2023 – 14:01

    Aurisco

    Aurisco Expands Oligonucleotide Capacity and Launches New Website

    SETÚBAL, Portugal (ots/PRNewswire) - The New State-of-Art OligoPilot 2000TM solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs. The new website shows how R&D and Innovation is the driving force of its sustainable growth, featuring its technologies, capabilities, services and products, including Oligonucleotides, peptides and small molecules ...

  • 20.03.2023 – 14:01

    Hovione

    Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space

    Lisbon, Portugal (ots/PRNewswire) - Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics, a leading ophthalmic sustained drug delivery company, have entered a strategic partnership to expand the use of Ripple's Epidel® platform beyond ophthalmic applications. The core feature of Ripple's Epidel® technology ...

  • 17.10.2018 – 17:36

    Hovione

    Hovione Increases Production Capacity

    Loures, Portugal (ots/PRNewswire) - 'One Site Shop' expands to respond to growing demands Hovione announces plan to increase production capacity in oral dosage forms in Portugal, to strengthen the integrated offering. New commercial scale equipment for blending, tableting and coating will complement existing development small scale equipment. This decision to expand follows growing customer demand since, one year ago ...

  • 06.08.2018 – 20:00

    MOV.AI

    MOV.AI Raises $3M in Seed Funding From Viola Ventures and NFX

    MOV.AI is developing the first industry-grade Operating System for autonomous intelligent collaborative robots for large-scale commercial deployment Lisbon, Portugal (ots/PRNewswire) - MOV.AI announced today that it raised $3M in seed funding to develop the first industry-grade O/S for autonomous intelligent collaborative robots. As such, MOV.AI is creating an ecosystem where developers, integrators and manufacturers ...

  • 24.01.2018 – 15:31

    Hovione

    Hovione Strengthens Inhalation Services Portfolio

    Loures, Portugal (ots/PRNewswire) - Hovione announced that a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities. This investment reinforces Hovione's Services portfolio in inhalation product development capabilities (http://www.hovione.com/products-and-services/contract-manufacturing-services/drug-product/innovation-and-expertise), which include proprietary particle engineering ...

  • 13.09.2017 – 16:32

    Novo Nordisk

    Xultophy® Reduces Cardiovascular Risk Factors in People with Type 2 Diabetes

    Lisbon, Portugal (ots/PRNewswire) - Oral Presentation 113 In people with type 2 diabetes, Xultophy® (insulin degludec/liraglutide) significantly reduced a number of risk factors associated with an increased risk of cardiovascular disease (CVD), compared to basal insulin.[1] According to a new post-hoc analysis presented today at the 53rd Annual Meeting of the European ...

  • 01.06.2017 – 14:17

    World Life Experience

    World Life Experience - Travel, Discover and Share with the World

    Lisbon, Portugal (ots/PRNewswire) - Around the world in 365 days - all expenses paid plus a salary and an incredible opportunity for a group of 12 people to travel, discover, and share with the world. World Life Experience is an international event that can best be described as the journey of a lifetime. It is in search of 12 people - 6 women and 6 men, between the ages of 20 and 35 from around the globe to take a 1-year ...

  • 16.03.2015 – 11:23

    Porto Cruz

    A New Design for Porto Cruz

    Porto, Portugal (ots/PRNewswire) - CRUZ, the No.1 Port in the World, has unveiled a new and elegant design for its classic range. A brand new look designed to retain the elegant style of CRUZ and to give a superior brand visibility. To view the Multimedia News Release, please click: http://www.multivu.com/players/English/7462151-new-design-porto-cruz The new packaging will be available worldwide and will be rolled out on all the qualities: Tawny, White, Ruby, Special Reserve ...